
    
      A multicenter, open-label extension study to assess the long-term safety and tolerability of
      lacosamide as adjunctive therapy in subjects with partial-onset seizures who were previously
      enrolled in the SP925 study [NCT00655551] (intravenous lacosamide loading dose followed by
      approximately 1 week of oral lacosamide maintenance).
    
  